Enzo Biochem Inc (ENZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Enzo Biochem Inc (ENZ) has a cash flow conversion efficiency ratio of -0.074x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.22 Million) by net assets ($43.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Enzo Biochem Inc worth for the company's overall valuation and market capitalisation.
Enzo Biochem Inc - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Enzo Biochem Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Enzo Biochem Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Enzo Biochem Inc ranked by their cash flow conversion efficiency. Explore how high is Enzo Biochem Inc's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genenta Science SpA ADR
NASDAQ:GNTA
|
-0.077x |
|
Korean Air Lines Co Ltd
KO:003495
|
0.185x |
|
Brite Tech Bhd
KLSE:0011
|
0.060x |
|
Pure Resources Ltd
AU:PR1
|
-0.214x |
|
BR.SCH.ED.HLD.SP.ADR CL.A
F:BSK0
|
N/A |
|
MOUNTAIN VALLEY MD HLDGS
F:20MP
|
N/A |
|
Careplus Group Bhd
KLSE:0163
|
-0.058x |
|
KB SPAC 5
KQ:208350
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Enzo Biochem Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of Enzo Biochem Inc from 1989 to 2024. View current stock price of Enzo Biochem Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $56.11 Million | $-26.26 Million | -0.468x | +0.70% |
| 2023-07-31 | $78.46 Million | $-36.98 Million | -0.471x | -54.71% |
| 2022-07-31 | $54.46 Million | $-16.59 Million | -0.305x | -5498.55% |
| 2021-07-31 | $68.59 Million | $387.00K | 0.006x | +101.92% |
| 2020-07-31 | $58.38 Million | $-17.18 Million | -0.294x | -626.72% |
| 2019-07-31 | $86.03 Million | $4.81 Million | 0.056x | +265.70% |
| 2018-07-31 | $81.12 Million | $-2.73 Million | -0.034x | -1361.62% |
| 2017-07-31 | $88.87 Million | $-205.00K | -0.002x | -100.39% |
| 2016-07-31 | $89.55 Million | $53.13 Million | 0.593x | +783.11% |
| 2015-07-31 | $42.61 Million | $-3.70 Million | -0.087x | -89.09% |
| 2014-07-31 | $36.95 Million | $-1.70 Million | -0.046x | +84.35% |
| 2013-07-31 | $34.13 Million | $-10.02 Million | -0.293x | -141.27% |
| 2012-07-31 | $49.10 Million | $-5.97 Million | -0.122x | -29.60% |
| 2011-07-31 | $88.72 Million | $-8.33 Million | -0.094x | +32.37% |
| 2010-07-31 | $97.02 Million | $-13.46 Million | -0.139x | -41.21% |
| 2009-07-31 | $116.78 Million | $-11.48 Million | -0.098x | -58.70% |
| 2008-07-31 | $138.29 Million | $-8.56 Million | -0.062x | -133.33% |
| 2007-07-31 | $141.89 Million | $-3.77 Million | -0.027x | +74.94% |
| 2006-07-31 | $95.59 Million | $-10.12 Million | -0.106x | -189.40% |
| 2005-07-31 | $108.27 Million | $12.83 Million | 0.118x | +321.11% |
| 2004-07-31 | $104.17 Million | $-5.58 Million | -0.054x | -148.36% |
| 2003-07-31 | $109.38 Million | $12.12 Million | 0.111x | +21.42% |
| 2002-07-31 | $104.73 Million | $9.56 Million | 0.091x | +11.29% |
| 2001-07-31 | $97.52 Million | $8.00 Million | 0.082x | +44.96% |
| 2000-07-31 | $87.18 Million | $4.93 Million | 0.057x | -61.47% |
| 1999-07-31 | $75.60 Million | $11.10 Million | 0.147x | +21.71% |
| 1998-07-31 | $68.80 Million | $8.30 Million | 0.121x | +0.27% |
| 1997-07-31 | $64.00 Million | $7.70 Million | 0.120x | +9.07% |
| 1996-07-31 | $55.30 Million | $6.10 Million | 0.110x | -25.94% |
| 1995-07-31 | $61.10 Million | $9.10 Million | 0.149x | +338.30% |
| 1994-07-31 | $51.20 Million | $-3.20 Million | -0.063x | -352.34% |
| 1993-07-31 | $32.30 Million | $800.00K | 0.025x | -61.08% |
| 1992-07-31 | $33.00 Million | $2.10 Million | 0.064x | +103.04% |
| 1991-07-31 | $1.10 Million | $-2.30 Million | -2.091x | -420.68% |
| 1990-07-31 | $12.70 Million | $-5.10 Million | -0.402x | -29.02% |
| 1989-07-31 | $15.10 Million | $-4.70 Million | -0.311x | -- |
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more